Target intelligence / Profile preview

Major histocompatibility complex, class I, F pseudogene (MHC class I F pseudogene (no widely used standard abbreviation; HLA-F pseudogene if aligned to human convention))

Target
MHC class I F pseudogene (no widely used standard abbreviation; HLA-F pseudogene if aligned to human convention)
Molecular classification
Other, Pseudogene
01

Overview

The major histocompatibility complex, class I, F pseudogene (ENSG00000262990) is a nonfunctional genomic segment, derived from the protein-coding gene HLA-F, part of the MHC class I family. MHC molecules play key roles in immune response and antigen presentation, but this specific entry does not code for a functional protein. Pseudogenes like this may participate in gene regulation at the RNA level through mechanisms such as competing endogenous RNA or small interfering RNA (siRNA) production, but there is no direct evidence of such function for this pseudogene[2]. Functional MHC class I molecules—including classical (e.g., HLA-A, HLA-B, HLA-C) and non-classical (including HLA-F)—mediate immune cell interactions and antigen presentation, but the "F pseudogene" is not involved in these processes[1][3]. This entry should not be catalogued as a drug discovery or therapeutic target due to its nonfunctional and regulatory nature. If a functional MHC class I or HLA-F is intended, a search for “HLA-F” (not the pseudogene) is recommended.

Other names
HLA-F pseudogeneMHC class I F pseudogeneENSG00000262990
02

Mechanism of action

None (No therapeutic mechanism, as this is not a protein-coding or otherwise functional target.)

03

Biological functions

None (for this specific pseudogene; functional HLA-F has immune regulatory functions, but pseudogenes do not produce protein)Potential regulatory roles in gene expression through non-coding RNA pathways (as described for pseudogenes in general)[2]
04

Disease associations

Other (No direct role in disease; some pseudogenes can act through RNA-level regulation, but no evidence for this specific pseudogene in disease.)
05

Safety considerations

None
06

Interacting drugs

None
07

Biomarkers

None

Beyond the preview

Go deeper on Major histocompatibility complex, class I, F pseudogene (MHC class I F pseudogene (no widely used standard abbreviation; HLA-F pseudogene if aligned to human convention)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Major histocompatibility complex, class I, F pseudogene (MHC class I F pseudogene (no widely used standard abbreviation; HLA-F pseudogene if aligned to human convention)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call